Middle East Healthcare Co. (4009) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Middle East Healthcare Co. reported revenue of SAR 3.10B, net profit of SAR 302M, and earnings per share of SAR 3.28. Total assets stood at SAR 5.47B with total equity of SAR 1.87B and total liabilities of SAR 3.54B.

Operating cash flow for 2025 was SAR 545M, representing a cash conversion ratio of 1.80 relative to net profit. Free cash flow was SAR 206M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 1.80 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.80.

Revenue growth from 2024 to 2025: +7.6%. Net profit growth over the same period: +7.0%. 3-year revenue CAGR: 28.2%. 3-year net profit CAGR: 58.9%.

Key financial ratios for 2025: Return on Equity 16.1%, Return on Assets 5.5%, Net Margin 9.7%, Debt to Equity 1.89.

In 2024, Middle East Healthcare Co. reported revenue of SAR 2.88B and net profit of SAR 282M, compared to SAR 3.10B and SAR 302M respectively in 2025.